- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.11%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of UTI Healthcare Fund - Direct Plan - Growth Option and its peers as on 12 October, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| UTI Healthcare Fund - Direct Plan - Growth Option | 14.96% | -0.11% | -1.15% | -4.74% | -1.39% | 12.05% | 22.02% | 14.9% | 24.24% | 14.31% |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -13.1% | -0.63% | -1.05% | -3.92% | -7.93% | -13.86% | 3.32% | 9.38% | 14.05% | 13.19% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -9.27% | -0.36% | -1.13% | -4.41% | -6.43% | -7.22% | 6.89% | 6.53% | 11.91% | 11.01% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 18.31% | -0.09% | -0.81% | -5.43% | -0.64% | 15.21% | 22.4% | 17.45% | 25.64% | 14.35% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | -3.72% | -0.06% | -1.75% | -4.58% | -7.2% | -1.61% | 10.83% | 14.19% | 18.58% | 14.46% |
| SBI COMMA Fund - DIRECT PLAN - Growth | -0.56% | -0.13% | -2.5% | -6.68% | -4.5% | 3.48% | 13.3% | 8.38% | 18.08% | 13.97% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -8.69% | 6.51% | -6.14% | 2.51% | 69.29% | 19.54% | -11.56% | 40.84% | 43.58% | -2.13% |
Discrete returns (monthly)
| Month | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -1.82% | -4.85% | 3.82% | -4.68% | 7.66% | 4.03% | 7.28% | 2.96% | 3.09% | -2.91% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 14.92% | 7.28% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 94.24% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 5.73% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Other links |
|---|---|---|---|---|
| EQ - SUN PHARMACEUTICALS INDUSTRIES | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 8.25% | |
| EQ - DIVIS LABORATORIES LTD. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 6.21% | |
| EQ - AJANTA PHARMA LTD. | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 4.74% | |
| EQ - GLAND PHARMA LTD. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 3.70% | |
| EQ - DR REDDYS LABORATORIES LTD. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 3.62% | |
| EQ - ALKEM LABORATORIES LTD | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 3.29% | |
| EQ - APOLLO HOSPITALS ENTERPRISE LT | APOLLOHOSP (INE437A01024) | Healthcare Services | 3.27% | |
| EQ - MAX HEALTHCARE INSTITUTE LTD | MAXHEALTH (INE027H01010) | Healthcare Services | 3.10% | |
| EQ - LUPIN LTD. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 3.09% | |
| EQ - CAPLIN POINT LABORATORIES LTD | CAPLIPOINT (INE475E01026) | Pharmaceuticals & Biotechnology | 3.05% | |
| EQ - IPCA LABORATORIES LTD. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 2.87% | |
| EQ- GLOBAL HEALTH LTD. | MEDANTA (INE474Q01031) | Healthcare Services | 2.81% | |
| EQ - ANTHEM BIOSCIENCES LTD | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 2.62% | |
| EQ - FORTIS HEALTHCARE LTD. | FORTIS (INE061F01013) | Healthcare Services | 2.36% | |
| EQ - RAINBOW CHILDRENS MEDICARE LTD | RAINBOW (INE961O01016) | Healthcare Services | 2.25% | |
| EQ - MARKSANS PHARMA LTD. | MARKSANS (INE750C01026) | Pharmaceuticals & Biotechnology | 2.23% | |
| EQ - GLENMARK PHARMACEUTICALS LTD. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.23% | |
| EQ - COHANCE LIFESCIENCES LIMITED | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 2.21% | |
| EQ- JUPITER LIFE LINE HOSPITALS LTD | (INE682M01020) | Healthcare Services | 2.17% | |
| EQ - AUROBINDO PHARMA LTD. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.10% | |
| EQ - PROCTOR & GAMBLE HEALTH LTD | PGHL (INE199A01012) | Pharmaceuticals & Biotechnology | 2.00% | |
| EQ - ASTER DM QUALITY CARE LIMITED | ASTERDM (INE914M01019) | Healthcare Services | 1.89% | |
| EQ - SAI LIFE SCIENCES LTD | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 1.79% | |
| EQ - DR LAL PATHLABS LTD. | LALPATHLAB (INE600L01024) | Healthcare Services | 1.61% | |
| EQ - METROPOLIS HEALTHCARE LTD | METROPOLIS (INE112L01020) | Healthcare Services | 1.56% | |
| EQ - VIYASH SCIENTIFIC LTD | VIYASH (INE807F01027) | Pharmaceuticals & Biotechnology | 1.54% | |
| EQ - CIPLA LTD. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 1.46% | |
| EQ - SUDEEP PHARMA LIMITED | SUDEEPPHRM (INE0QPI01025) | Chemicals & Petrochemicals | 1.42% | |
| EQ - BIOCON LTD. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.42% | |
| EQ - VIJAYA DIAGNOSTIC CENTRE LTD | VIJAYA (INE043W01024) | Healthcare Services | 1.39% | |
| EQ - WINDLAS BIOTEC LTD | WINDLAS (INE0H5O01029) | Pharmaceuticals & Biotechnology | 1.28% | |
| EQ - ERIS LIFESCIENCES LTD | ERIS (INE406M01024) | Pharmaceuticals & Biotechnology | 1.21% | |
| EQ - ALEMBIC PHARMACEUTICALS | APLLTD (INE901L01018) | Pharmaceuticals & Biotechnology | 1.16% | |
| EQ - MANIPAL HEALTH ENTERPRISES LIMITED | (INE459N01021) | Healthcare Services | 1.12% | |
| EQ - PFIZER LIMITED | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 1.11% | |
| EQ - BLUE JET HEALTHCARE LTD | BLUEJET (INE0KBH01020) | Pharmaceuticals & Biotechnology | 0.99% | |
| EQ - LAXMI DENTAL LIMITED | LAXMIDENTL (INE0WO601020) | Healthcare Equipment & Supplies | 0.98% | |
| EQ - EMCURE PHARMACEUTICALS LTD | EMCURE (INE168P01015) | Pharmaceuticals & Biotechnology | 0.89% | |
| EQ - AARTI PHARMALABS LTD | AARTIPHARM (INE0LRU01027) | Pharmaceuticals & Biotechnology | 0.88% | |
| EQ - SANOFI CONSUMER HEALTHCARE INDIA LTD | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 0.69% | |
| EQ - ORCHID PHARMA LTD. | ORCHPHARMA (INE191A01027) | Pharmaceuticals & Biotechnology | 0.68% | |
| EQ - JUBILANT PHARMOVA LIMITED | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 0.55% | |
| EQ - SYNGENE INTERNATIONAL LTD. | SYNGENE (INE398R01022) | Healthcare Services | 0.45% |
Portfolio data is as on date 31 August, 2026
NAV history
UTI Healthcare Fund - Direct Plan - Growth Option - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 12 October, 2026 | 370.6817 | -0.11% |
| 9 October, 2026 | 371.1075 | 0.51% |
| 8 October, 2026 | 369.2199 | -2.45% |
| 7 October, 2026 | 378.49 | -0.01% |
| 6 October, 2026 | 378.523 | 0.94% |
| 5 October, 2026 | 374.9996 | -0.96% |
| 1 October, 2026 | 378.6495 | -0.32% |
| 30 September, 2026 | 379.8786 | -2.19% |
| 29 September, 2026 | 388.3981 | 0.38% |
| 28 September, 2026 | 386.9382 | -1% |
| 25 September, 2026 | 390.833 | -0.47% |
| 24 September, 2026 | 392.6752 | -0.59% |
| 23 September, 2026 | 394.9941 | 0.7% |
| 22 September, 2026 | 392.2582 | -0.47% |
| 21 September, 2026 | 394.1051 | 0.53% |
| 18 September, 2026 | 392.0411 | 1.13% |
| 17 September, 2026 | 387.6596 | 1.36% |
| 16 September, 2026 | 382.4503 | -0.22% |
| 15 September, 2026 | 383.3021 | -1.5% |
| 11 September, 2026 | 389.1296 | -0.44% |
| 10 September, 2026 | 390.8579 | -0.45% |
| 9 September, 2026 | 392.6351 | -0.15% |
| 8 September, 2026 | 393.2199 | 0.34% |
| 7 September, 2026 | 391.8974 | 0.28% |
| 4 September, 2026 | 390.8008 | -0.38% |
| 3 September, 2026 | 392.3081 | 0.45% |
| 2 September, 2026 | 390.5497 | -0.18% |
| 1 September, 2026 | 391.2724 | -0.37% |
| 31 August, 2026 | 392.7383 | 0.48% |
| 28 August, 2026 | 390.8449 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of UTI Healthcare Fund - Direct Plan - Growth Option?
The latest NAV of UTI Healthcare Fund - Direct Plan - Growth Option is 370.6817 as on 12 October, 2026.What are YTD (year to date) returns of UTI Healthcare Fund - Direct Plan - Growth Option?
The YTD (year to date) returns of UTI Healthcare Fund - Direct Plan - Growth Option are 14.96% as on 12 October, 2026.What are 1 year returns of UTI Healthcare Fund - Direct Plan - Growth Option?
The 1 year returns of UTI Healthcare Fund - Direct Plan - Growth Option are 12.05% as on 12 October, 2026.What are 3 year CAGR returns of UTI Healthcare Fund - Direct Plan - Growth Option?
The 3 year annualized returns (CAGR) of UTI Healthcare Fund - Direct Plan - Growth Option are 22.02% as on 12 October, 2026.What are 5 year CAGR returns of UTI Healthcare Fund - Direct Plan - Growth Option?
The 5 year annualized returns (CAGR) of UTI Healthcare Fund - Direct Plan - Growth Option are 14.9% as on 12 October, 2026.What are 10 year CAGR returns of UTI Healthcare Fund - Direct Plan - Growth Option?
The 10 year annualized returns (CAGR) of UTI Healthcare Fund - Direct Plan - Growth Option are 14.9% as on 12 October, 2026.What are top 10 holdings of UTI Healthcare Fund - Direct Plan - Growth Option?
Top 10 holdings of UTI Healthcare Fund - Direct Plan - Growth Option are:- EQ - SUN PHARMACEUTICALS INDUSTRIES
- EQ - DIVIS LABORATORIES LTD.
- EQ - AJANTA PHARMA LTD.
- EQ - GLAND PHARMA LTD.
- EQ - DR REDDYS LABORATORIES LTD.
- EQ - ALKEM LABORATORIES LTD
- EQ - APOLLO HOSPITALS ENTERPRISE LT
- EQ - MAX HEALTHCARE INSTITUTE LTD
- EQ - LUPIN LTD.
- EQ - CAPLIN POINT LABORATORIES LTD
- EQ - IPCA LABORATORIES LTD.
What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for UTI Healthcare Fund - Direct Plan - Growth Option?
UTI Healthcare Fund - Direct Plan - Growth Option is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)Holding period Tax rate Less than 1 year (STCG) 20% More than 1 year (LTCG) Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.